Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor
- PMID: 21098986
- DOI: 10.3233/JAD-2010-100021
Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor
Abstract
The blood-brain barrier (BBB) influences brain levels of amyloid-β (Aβ) by transporting Aβ out of the brain (efflux) and by the reabsorption of cerebrospinal fluid (CSF) into the blood stream (bulk flow). In Alzheimer's disease (AD) and normal aging, unknown factors impair Aβ efflux and bulk flow in aging and in AD. These impairments have been proposed as mechanisms by which the Aβ burden in brain can increase. Impairment in Aβ efflux occurs in animal models of AD, including the aged SAMP8 mouse. Here, we show that CSF reabsorption is also reduced by about 50% in SAMP8 mice (p < 0.05). We then determined whether an antisense directed at the Aβ region of the amyloid-β protein precursor (AβPP) and previously shown to decrease brain levels of AβPP and to reverse the cognitive impairments of the SAMP8 mouse was able to reverse these impairments. We found that the antisense restored both the CSF reabsorption, more than doubling the rate of efflux, and the saturable efflux of Aβ. These findings suggest that AβPP/Aβ itself contributes to the impairments in bulk flow and saturable efflux of Aβ and that reduction of AβPP/Aβ levels can restore normal function of the BBB.
Similar articles
-
Peripheral administration of antisense oligonucleotides targeting the amyloid-β protein precursor reverses AβPP and LRP-1 overexpression in the aged SAMP8 mouse brain.J Alzheimers Dis. 2012;28(4):951-60. doi: 10.3233/JAD-2011-111517. J Alzheimers Dis. 2012. PMID: 22179572
-
Delivery across the blood-brain barrier of antisense directed against amyloid beta: reversal of learning and memory deficits in mice overexpressing amyloid precursor protein.J Pharmacol Exp Ther. 2001 Jun;297(3):1113-21. J Pharmacol Exp Ther. 2001. PMID: 11356936
-
4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.J Alzheimers Dis. 2011;27(1):127-41. doi: 10.3233/JAD-2011-110545. J Alzheimers Dis. 2011. PMID: 21799245
-
Functional roles of amyloid-beta protein precursor and amyloid-beta peptides: evidence from experimental studies.J Alzheimers Dis. 2009;18(2):401-12. doi: 10.3233/JAD-2009-1154. J Alzheimers Dis. 2009. PMID: 19584429 Review.
-
Regulated proteolysis of RAGE and AbetaPP as possible link between type 2 diabetes mellitus and Alzheimer's disease.J Alzheimers Dis. 2009;16(4):865-78. doi: 10.3233/JAD-2009-0998. J Alzheimers Dis. 2009. PMID: 19387119 Review.
Cited by
-
Insights into Pharmacological Activities of Nicotine and 6-Hydroxy-L-nicotine, a Bacterial Nicotine Derivative: A Systematic Review.Biomolecules. 2023 Dec 23;14(1):23. doi: 10.3390/biom14010023. Biomolecules. 2023. PMID: 38254623 Free PMC article. Review.
-
Central and peripheral administration of antisense oligonucleotide targeting amyloid-β protein precursor improves learning and memory and reduces neuroinflammatory cytokines in Tg2576 (AβPPswe) mice.J Alzheimers Dis. 2014;40(4):1005-16. doi: 10.3233/JAD-131883. J Alzheimers Dis. 2014. PMID: 24577464 Free PMC article.
-
Expression and function of Abcg4 in the mouse blood-brain barrier: role in restricting the brain entry of amyloid-β peptide.Sci Rep. 2017 Oct 17;7(1):13393. doi: 10.1038/s41598-017-13750-0. Sci Rep. 2017. PMID: 29042617 Free PMC article.
-
Cellular senescence and the blood-brain barrier: Implications for aging and age-related diseases.Exp Biol Med (Maywood). 2023 May;248(5):399-411. doi: 10.1177/15353702231157917. Epub 2023 Apr 3. Exp Biol Med (Maywood). 2023. PMID: 37012666 Free PMC article. Review.
-
Lipopolysaccharide impairs amyloid β efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier.J Neuroinflammation. 2012 Jun 29;9:150. doi: 10.1186/1742-2094-9-150. J Neuroinflammation. 2012. PMID: 22747709 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
